regn5458
regeneron pharmaceuticals
#ims2022 | the phase ii part of regn5458 is moving forward recruiting patients after the initial results presented by naresh bumma #bispecific #mmsm read more here: 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma